Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3BNC117 during analytical treatment interruption in HIV
NCT02446847Phase 2Completed
- Sponsor
- The Rockefeller University
- Start
- Mar 2015
- Primary completion
- Mar 2017
- Modality
- Anti-infectious Disease mAbs
- Countries
- 1
01
Overview
A Phase 2 trial of Teropavimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by The Rockefeller University. Started Mar 2015; status: completed.
02
Drugs
Teropavimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02446847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446847.